{
    "root": "35ced36e-d65c-4dca-e063-6294a90ae85c",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Megestrol Acetate",
    "value": "20250523",
    "ingredients": [
        {
            "name": "SODIUM BENZOATE",
            "code": "OJ245FE5EU",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_113455"
        },
        {
            "name": "SODIUM CITRATE",
            "code": "1Q73Q2JULR",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_53258"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17992"
        },
        {
            "name": "CITRIC ACID MONOHYDRATE",
            "code": "2968PHW8QP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31404"
        },
        {
            "name": "DOCUSATE SODIUM",
            "code": "F05Q2T2JA0",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11089"
        },
        {
            "name": "GLYCERIN",
            "code": "PDC6A3C0OX",
            "drugbank_id": "https://go.drugbank.com/drugs/DB09462"
        },
        {
            "name": "XANTHAN GUM",
            "code": "TTV12P4NEE",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_189560"
        },
        {
            "name": "MEGESTROL ACETATE",
            "code": "TJ2M0FR8ES",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6723"
        }
    ],
    "indications": {
        "text": "megestrol acetate oral suspension , usp indicated treatment anorexia , cachexia , unexplained , significant weight loss patients diagnosis acquired immunodeficiency syndrome ( aids ) .",
        "doid_entities": [
            {
                "text": "acquired immunodeficiency syndrome (DOID:635)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_635"
            },
            {
                "text": "immunodeficiency syndrome (DOID:612)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_612"
            },
            {
                "text": "syndrome (DOID:225)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_225"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "immunodeficiency",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_101997"
            }
        ]
    },
    "contraindications": {
        "text": "recommended adult initial megestrol acetate oral suspension , usp 800 mg/day ( 20 ml/day ) . shake container well using . trials evaluating different dose schedules , daily doses 400 800 mg/day found clinically effective .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "megestrol acetate oral suspension , usp available milky white , lemon-lime flavored oral suspension containing 40 mg micronized megestrol acetate per ml . ndc 17856-0060-01 10ml ndc 17856-0060-02 20ml storage : store oral suspension 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) . [ usp ] . dispense tight container . protect heat . special handling : health hazard data : threshold limit value established osha , niosh , acgih . exposure `` overdose `` levels approaching recommended dosing levels could result side effects described ( warningsand ) . women risk pregnancy avoid exposure . distributed : atlantic biologicals corp. miami , fl 33179",
    "adverseReactions": "history hypersensitivity megestrol acetate component formulation . known suspected pregnancy .",
    "indications_original": "Megestrol acetate oral suspension, USP is indicated for the treatment of anorexia, cachexia, or an unexplained, significant weight loss in patients with a diagnosis of acquired immunodeficiency syndrome (AIDS).",
    "contraindications_original": "The recommended adult initial dosage of megestrol acetate oral suspension, USP is 800 mg/day (20 mL/day). Shake container well before using.\n                  In clinical trials evaluating different dose schedules, daily doses of 400 and 800 mg/day were found to be clinically effective.",
    "warningsAndPrecautions_original": "Megestrol acetate oral suspension, USP is available as a milky white, lemon-lime flavored oral suspension containing 40 mg of micronized megestrol acetate per mL.\n                  NDC 17856-0060-01 10ML\u00a0\n                  NDC 17856-0060-02\u00a0 20ML\u00a0\n                  STORAGE:\n                  Store the oral suspension between 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F). [See USP]. Dispense in a tight container. Protect from heat.\n                  SPECIAL HANDLING:\n                  Health Hazard Data: There is no threshold limit value established by OSHA, NIOSH, or ACGIH.\n                  Exposure or \"overdose\" at levels approaching recommended dosing levels could result in side effects described above (see\n \n  WARNINGSand\n \n  ADVERSE REACTIONS). Women at risk of pregnancy should avoid such exposure.\n\n \n                  \n                     Distributed by:\n                  \n                  ATLANTIC BIOLOGICALS CORP.\n                  MIAMI, FL 33179",
    "adverseReactions_original": "History of hypersensitivity to megestrol acetate or any component of the formulation. Known or suspected pregnancy.",
    "drug": [
        {
            "name": "Megestrol Acetate",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_6723"
        }
    ]
}